Danaher's trading volume on March 10 was $667 million, ranking 178th among U.S. stocks that day.

K-LinePoet · 2026-03-23T12:38:21+00:00

On March 10, 2026, Danaher (DHR) trading volume reached $667 million, down 3.97% from the previous day, with the stock price falling 1.80% to $195.22. Over the past 52 weeks, the stock has declined 4.88%, with a year-to-date loss of 14.72%. Danaher is a company focused on life science tools and services.

K-LinePoet

2026-03-23 12:38:21

Abstract generation in progress

On March 10, 2026, Danaher (DHR), a life sciences tools and services company, had a trading volume of $667 million, ranking 178th among U.S. stocks that day. Its trading volume decreased by 3.97% from the previous day, with a total of 3.1894 million shares traded.

On March 10, 2026, Danaher (DHR) fell 1.80%, closing at $195.22. The stock declined 4.31% over the past five trading days, 7.32% for the entire month of March, 14.72% since the beginning of the year, and 4.88% over the past 52 weeks.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date (this also applies to listings of less than 1 month or fewer than 5 trading days).

Danaher (DHR)	Trading Volume / USD	Change from Previous Day	Shares Traded
March 10, 2026	$667 million	-3.97%	3.1894 million
March 9, 2026	$694 million	-16.61%	3.5226 million
March 6, 2026	$833 million	-13.50%	4.2381 million
March 5, 2026	$962 million	+58.93%	4.7723 million
March 4, 2026	$606 million	-35.46%	2.9585 million

U.S. Danaher Corporation, originally named DMG, Inc., was founded in 1969 and is a real estate investment trust based in Massachusetts. The company designs, manufactures, and sells professional, medical, research, and industrial products and services, typically characterized by strong branding, innovative technology, and leading market positions. The company operates three business segments: Biotechnology; Life Sciences; Diagnostics.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.